CPT® Code 82776

1. Indications

The screening for galactose-1-phosphate uridyl transferase (GALT) is indicated for the following conditions:

• Newborn Screening This test is performed as part of a panel to screen newborns for metabolic disorders, particularly to identify those at risk for classic type galactosemia.

2. Procedure

The procedure for screening galactose-1-phosphate uridyl transferase (GALT) involves several key steps:

• Blood Sample Collection A blood sample is obtained from the newborn through a venipuncture, which is a standard method for drawing blood. This step is crucial as it provides the necessary specimen for testing.
• Enzymatic Testing The collected blood sample is then subjected to enzymatic methodology to detect the presence of GALT. This testing process is designed to measure the activity of the enzyme, which is indicative of the metabolic function related to galactose processing.

3. Post-Procedure

After the GALT screening test is performed, the results are typically reviewed by healthcare professionals. If the screening indicates a deficiency or absence of GALT, further diagnostic testing may be warranted to confirm the diagnosis of classic type galactosemia. It is essential for healthcare providers to monitor the newborn's health closely and provide appropriate dietary recommendations to manage galactose intake, thereby preventing potential complications associated with the disorder.